StoneX Group’s Medical Properties Trust MPT Stock Holding History

StoneX Group’s Portfolio MPT Stock Details MPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-12,627	Closed	-$50.3K	–	935
2024 Q4	$50.3K	Buy	+12,627	New	+$56.6K	﹤0.01%	784

Other funds holding MPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

DFG

Demars Financial Group Spokane Valley, Washington $361M AUM 24.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

StoneX Group's MPT Position: Q1 2025 in Review

StoneX Group sold out of Medical Properties Trust (MPT) in Q1 2025, closing a stake of 12,627 shares — an estimated $50.3K sold.

StoneX Group first reported a position in MPT in Q4 2024 and held it in 1 quarter. The position peaked at $50.3K in Q4 2024. 470 funds tracked by Wall St. Rank hold MPT as of Q1 2025.

StoneX Group reported no remaining Medical Properties Trust position as of Q1 2025 after selling out during the quarter.
StoneX Group sold 12,627 Medical Properties Trust shares in Q1 2025, an estimated $50.3K.
StoneX Group first reported a position in Medical Properties Trust in Q4 2024 and held it in 1 quarter.
StoneX Group's Medical Properties Trust position peaked at $50.3K in Q4 2024.
470 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2025.

Based on StoneX Group's 13F filing for Q1 2025, filed 15 May 2025.